Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study

Journal of Internal Medicine

Volumn 242, Issue 4, 1997, Pages 339-347

  Bots, M L ^a,b   Launer, L J ^a,c   Lindemans, J ^a   Hofman, A ^a   Grobbee, D E ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Intima media thickness; Myocardial infarction; Plaques; Risk; Stroke

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; AGING; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030698745     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.00239.x     Document Type: Article

References (29)

1. Ueland PM, Refsum U, Brattstrom L. Plasma homocysteine and cardiovascular disease. In: Francis DB Jr, ed. . . New York (NY): Marcel Dekker Inc., 1992: 183-236.
2. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395-8.
3. Dalery K, Lussier-Cacan S, Selhub J, Davignon J, Latour Y, Genest J. Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins b12, b6, pyridoxal phosphate, and folate. Am J Cardiol 1995; 75: 1107-11.
4. Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordre JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995; 24: 704-9.
5. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995; 274: 1049-57.
6. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid intimal-medial wall thickening and plasma homocysteine in asymptomatic adults. The Atherosclerosis Risk in Communities study. Circulation 1993; 87: 1107-13.
7. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ. Association between plasma homocysteine concentrations and extracranial carotid artery disease. N Engl J Med 1995; 532: 286-91.
8. Hofman A, Grobbee DE, De Jong PTVM, Vandenouweland FAM. Determinants of disease and disability in the elderly. The Rotterdam Elderly Study. Eur J Epidemiol 1991; 7: 403-22.
9. Bots ML, Looman SJ, Koudstaal PJ, Hofman A, Grobbee DE. Prevalence of stroke in the general population. The Rotterdam study. Stroke 1996; 27: 1499-501.
10. Bots ML, Hofman A, Grobbee DE. Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study. Arterioscler Thromb 1994; 14: 1885-91.
11. Rots ML, Mulder PGH, Hofman A, van Es GA, Grobbee DE. Reproducibility of carotid vessel wall thickness measurements. The Rotterdam Study. J Clin Epidemiol 1994; 47: 921-30.
12. Bots ML, Hofman A, Grobbee DE. Common carotid intima-media thickness as indicator of atherosclerosis elsewhere in the carotid artery. Ann Epidemiol 1996; 6: 147-53.
13. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the ageing process: A review. J Clin Epidemiol 1992; 45: 529-42.
14. Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, van Harskamp F. Atherosclerosis, apolipoprotein E and the prevalence of dementia and Alzheimer's disease in a population based study: The Rotterdam Study. Lancet 1997; 549: 151-4.
15. Bom JG, van der Bots ML, Bruijn AM, de Hofman A, Grobbee DE. Measurement of β-thromboglobulin in the elderly. Findings from the Rotterdam Study. Fibrinolysis 1994; 8 (Suppl. 2): 157-9.
16. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatography 1987; 422: 43-52.
17. Ubbink JB, Vermaak WJH, Bissbort S. Rapid high performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatography 1991; 465: 441-6.
18. Stampfer MJ, Malinow MR, Willet WC, Newcomer LM. Upson B, Ullman D. . A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877-81.
19. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willet W, Stampfer MJ. A prospective study of plasma homocysteine and risk of ischemic stroke. Stroke 1994; 25: 1924-30.
20. Nygoard O, Vollset SE, Refsum H, Stenvold I, Iverdal A, Nordrehang JE. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995; 274: 1526-55.
21. Harker LA, Slichter SJ, Scott CR, Ross R. Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med 1974; 291: 537-43.
22. McDonald L, Bray C, Field C, Love F, Davis B. Homocystinuria, thrombosis and the blood platelet. Lancet 1964; i: 745-6.
23. Harker LA, Ross R, Slichter SJ, Scott CR. Homocysteine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976; 58: 731-41.
24. Rodgers GM, Kane WH. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 1986; 77: 1909-16.
25. Rodgers GM, Conn MT. Homocysteine an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 1990; 75: 895-901.
26. Maruyama I, Fukuda R, Kazama M, Abe T, Yoshida Y, Igats A. A case of homocystinuria with low antithrombin activity. Acta Haematol Jpn 1977; 40: 267-71.
27. Bienvu T, Ankri A, Chadefaux B, Montalescot G, Kamoun P. Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters. Throm Res 1993; 70: 123-9.
28. Eckardstein A, von Malinow MR, Upson B, Heinrich J, Schulte H, Schonefeld R. Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men. Arterioscler Thromb 1994; 14: 460-64.
29. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabart RR, North WRS. . Haemostatic function and ischemic heart disease: principle results of the Northwick Park Heart Study. Lancet 1986; ii: 533-7.